Similar results were obtained with GLPK5 (glycerol Kinase 5) taking into account the BCR development, however, it is worth noting that this protein was able to distinguish patients with Gleason score 7 who developed BCR from those who did not, therefore, this candidate could be useful in predicting tumor behavior in patients with uncertain risk of progressing. Here, BCR is linked to neoplasm.